Corvex Inc. Common Stock (MOVE)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Movano Q2 Earnings Call Highlights
Corvex reported $3.8 million in second-quarter 2026 revenue, its first full reporting period including the AI cloud computing business acquired through its March merger with Corvex Legacy Holdings. Company leaders said the quarter's reported revenue reflected the amount of computing capacity that was live and generating revenue during the period, rather than the full level of signed customer commitments.
UNIVERSAL MUSIC'S SUDDEN MOVE FROM QUALITY GROWTH STOCK TO FALLEN ANGEL
Since going public nearly five years ago, Universal Music Group has traded at a valuation befitting a high-quality compounder with a median forward price-to-earnings multiple of almost 25 times — a huge 50% premium to the equal-weighted S&P 500, per FactSet. And indeed, UMG has many of the attributes of a great business: dominant market share, sustainable competitive advantages, annuity-like recurring revenue, above average organic growth, high returns on invested capital, and an inherently stable business model.
Corvex, Inc. (MOVE) Q1 2026 Earnings Call Prepared Remarks Transcript
Corvex, Inc. (MOVE) Q1 2026 Earnings Call Prepared Remarks Transcript
Corvex Inc. Common Stock Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CS Carl Schmidtman Dorsey & Whitney Trust Co. LLC | 50,969 | $603,527.61 | $434,765.57 | -$168,762.04 | -27.96% |
| AWM Accurate Wealth Management LLC Accurate Wealth Management LLC | 498,646 | $5.86M | $3.97M | -$1.89M | -32.26% |
 Tyler Glazier New Millennium Group LLC | 26 | $216.06 | $218.79 | $2.73 | 1.26% |
 KURT TRAULSEN EVOLUTION WEALTH MANAGEMENT INC. | 4 | $48.12 | $32.64 | -$15.48 | -32.17% |
Corvex Inc. Common Stock (MOVE) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Corvex Inc. Common Stock ever had a stock split?
Corvex Inc. Common Stock Profile
| Financial Services Industry | Financials Sector | Seth Demsey CEO | NASDAQ (CM) Exchange | 62459M305 CUSIP |
| US Country | 38 Employees | - Last Dividend | 7 Apr 2026 Last Split | 5 Aug 1999 IPO Date |
Overview
Movano Inc. is a pioneering health technology company that strives to bridge the gap between medical-grade and consumer health devices through its innovative platform. Founded in 2018 and originally known as Maestro Sensors Inc., the company underwent a rebranding to Movano Inc. in August of the same year. Based in Pleasanton, California, Movano Inc.'s mission is to deliver comprehensive healthcare solutions that cater to the evolving needs of the modern consumer, focusing particularly on the well-being and health monitoring of women. Through their cutting-edge technology, Movano Inc. seeks to empower individuals with actionable health insights, combining the precision of medical devices with the accessibility and user-friendliness of consumer wearables.
Products and Services
- Evie Ring:
- System-on-a-Chip (SoC) for blood pressure and continuous glucose monitoring (CGM) systems:
A wearable device tailored specifically for women, designed to seamlessly integrate health and wellness tracking into daily life. The Evie Ring offers a wide range of metrics, including resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, and skin temperature variability. Additionally, it focuses on women's health needs by providing period and ovulation tracking, and menstrual symptom tracking. Beyond these health metrics, the Evie Ring also monitors general activity, such as steps taken, active minutes, calories burned, sleep stages, duration, and mood tracking, making it a comprehensive solution for wellness monitoring.
Movano Inc. is also in the process of developing advanced System-on-a-Chip (SoC) solutions aimed at revolutionizing the way blood pressure and glucose levels are monitored. These SoC solutions are being designed for integration into blood pressure or continuous glucose monitoring (CGM) systems, potentially setting new standards in the accuracy, usability, and efficiency of monitoring these critical health metrics. This technology underscores Movano's commitment to pushing the boundaries of health technology by enabling real-time, accurate health monitoring that can be seamlessly incorporated into everyday life.
Contact Information
